Kinetics of host immune responses and cytomegalovirus resistance in a liver transplant patient

Liver Transplantation

Volumn 15, Issue 10, 2009, Pages 1199-1203

  Schaffer, Kirsten ^a   Moran, Julie ^b   Duffy, Margaret ^b   McCormick, Aiden P ^a   Hall, William W ^b   Hassan, Jaythoon ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD4 ANTIGEN; CD8 ANTIGEN; DACLIZUMAB; FOSCARNET; GAMMA INTERFERON; GANCICLOVIR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; VALGANCICLOVIR; VIRUS DNA;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CYTOMEGALOVIRUS INFECTION; DNA DETERMINATION; DNA EXTRACTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FLOW CYTOMETRY; GENE DELETION; GENOTYPE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTION RISK; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; MALE; MEMORY CELL; MEMORY T LYMPHOCYTE; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PREDICTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SEROCONVERSION; T LYMPHOCYTE; TREATMENT OUTCOME; VIRUS LOAD; WILD TYPE;

EID: 70350539109     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21832     Document Type: Article

References (20)

1. Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Clin Transplant 2008;22:162-170.
2. Limaye A, Corey L, Koelle DM, Davis CL, Boeckh M. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 2000;356:645-649. (Pubitemid 30627592)
3. Boivin G, Goyette N, Gilbert C, Humar A, Covington E. Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients. Transplant Infect Dis 2005;7:166-170. (Pubitemid 43015456)
4. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002;8:379-385. (Pubitemid 34407033)
5. Baars PA, Ribiero Do Couto LM, Leusen JH, Hooibrink B, Kuijpers TW, Lens SM, van Lier RA. Cytolytic mechanisms and expression of activation-regulating receptors on effector- type CD8+ CD45RA+CD27- human T cells. J Immunol 2000;165:1910-1917. (Pubitemid 30648744)
6. Nordoy I, Muller F, Nordal KP, Rollag H, Aukrust P, Froland SS. Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection. Clin Exp Immunol 2000;120:333-337. (Pubitemid 30304230)
7. Cervera C, Filella X, Linares L, Pineda M, Esteva C, Anton A, et al. Th1/Th2 cytokine release pattern during in vivo cytomegalovirus disease in solid organ transplantation. Transplant Proc 2007;39:2233-2235. (Pubitemid 47432699)
8. Benz C, Holz G, Michel D, Awerkiew S, Dries V, Stippel D, et al. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient. Transplantation 2003;75:724-727. (Pubitemid 36337375)
9. Baldanti F, Lilleri D, Campanini G, Comolli G, Ridolfo AL, Rusconi S, Gerna G. Human cytomegalovirus double resistance in a donor-positive/recipient- negative lung transplant patient with an impaired CD4-mediated specific immune response. J Antimicrob Chemother 2004;53:536-539. (Pubitemid 38380258)
10. Bowen EB, Johnson MA, Griffiths PD, Emery VC. Development of a point mutation assay for the detection of human cytomegalovirus UL97 mutations associated with ganciclovir resistance. J Virol Methods 1997;68:225-234. (Pubitemid 27417783)
11. Boivin G, Goyette N, Gilbert C, Roberts N, Macey K, Paya C, et al. Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis 2004;189:1615-1618. (Pubitemid 38648289)
12. Martin M, Gilbert C, Covington E, Boivin G. Characterization of human cytomegalovirus (HCMV) UL97 mutations found in a valganciclovir/oral ganciclovir prophylactic trial by use of a bacterial artificial chromosome containing the HCMV genome. J Infect Dis 2006;194:579-583. (Pubitemid 44297841)
13. Pescovitz MD, Rabkin J, Merion RM, Paya CV, Pirsch J, Freeman RB, et al. Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother 2000;44:2811-2815. (Pubitemid 30737703)
14. Emery VC, Griffiths PD. Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proc Natl Acad Sci 2000;97:8039-8044.
15. Limaye AP. Ganciclovir-resistant cytomegalovirus in organ transplant recipients. Clin Infect Dis 2002;35:866-872.
16. Van den Berg AP, Meyaard SA, Otto WJ, von Son WJ, Klompmaker IJ, Mesander G, et al. Cytomegalovirus infection associated with a decreased proliferative capacity and increased rate of apoptosis of peripheral blood lymphocytes. Transplant Proc 1995;27:936-938.
17. Briceno J, de la Torre-Cisneros J, Alvarez-Kindelan A, Sanchez-Guijo, Pera C. Antiviral drugs can inhibit lymphocyte apoptosis induced by cytomegalovirus antigens. Transplant Proc 2001;33:1799-1800. (Pubitemid 32238070)
18. Chang WL, Baumgarth N, Yu D, Barry PA. Human cytomegalovirus- encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J Virol 2004;78:8720-8731. (Pubitemid 39025137)
19. Gamadia L, Remmerswaal EBM, Weel JF, Bemelman F, van Lier RA, Ten Berge IJM. Primary immune responses to human CMV: a critical role for IFN-γ-producing CD4+ T cells in protection against CMV disease. Blood 2003;101:2686-2692. (Pubitemid 36857631)
20. Homann D, Yeyton L, Oldstone BA. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 2001;7:913-919. (Pubitemid 32756428)